Exercise of Options

RNS Number : 4986J

Synairgen plc

12 June 2014

 



Synairgen plc

("Synairgen" or the "Company")

Exercise of Options

Synairgen (LSE: SNG), the respiratory drug development company, announces that it has today applied for 266,363 ordinary shares of one pence each (the "Option Shares") to be admitted to trading on the AIM Market of the London Stock Exchange ("AIM") ("Admission"). It is expected that Admission will occur and that dealings will commence in the Option Shares on 18 June 2014.

The Options Shares are being issued pursuant to the exercise of options by employees of the Company. The Options Shares will rank pari passu with the Company's existing ordinary shares.

Following Admission, the number of Ordinary Shares in issue and admitted to trading on AIM will be 78,587,254.

Contact

Synairgen plc Richard Marsden, CEO John Ward, Finance Director	[phone]
finnCap Ltd Geoff Nash Christopher Raggett	[phone]
Newgate Threadneedle Graham Herring Josh Royston	[phone]

 

END

 

 

MSCQKBDKBBKDFAD